Lung cancer is one of the leading causes of death in both males and females, and it is the
first causes of cancer-related deaths. Chemotherapy, surgery and radiotherapy are …

Non‐small‐cell lung cancer (NSCLC), which has a high rate of metastatic spread and drug
resistance, is the most common subtype of lung cancer. Therefore, NSCLC patients have a …

Background Ferroptosis, a form of regulated cell death by lipid peroxidation, was currently
considered as a key factor affecting the occurrence and progression in various cancers …

Immunotherapies, such as immune checkpoint inhibitors (ICIs) and chimeric antigen
receptor (CAR) T cells, have revolutionized the treatment of patients with advanced and …

Autophagy is a catabolic process that is essential to the maintenance of homeostasis
through the cellular recycling of damaged organelles or misfolded proteins, which sustains …

Nanomedicine application in cancer therapy is an urgency because of inability of current
biological therapies for complete removal of tumor cells. The development of smart and …

The efficacy of PD-1 therapy in non-small cell lung cancer (NSCLC) patients remains
unsatisfactory. Activating the STING pathway is a promising strategy to improve PD-1 …

Cancer poses a substantial global health challenge, necessitating the widespread use of
chemotherapy and radiotherapy. Despite these efforts, issues like resistance development …

The Programmed death-1 (PD-1) and its programmed death-ligand 1 (PD-L1) comprise the
PD-1/PD-L1 axis and maintain tumor immune evasion. Cancer immunotherapy based on …

Autophagy in alveolar macrophages (AMs) is an important mechanism for maintaining
immune homeostasis and normal lung tissue function, and insufficient autophagy in AMs …